National Medical Care Co. · TADAWUL:4005
National Medical Care — 9M 2024 Earnings Presentation
19 slides from National Medical Care's earnings presentation, Oct 21, 2024
Slide 1: Earnings Presentation 9M 2024
Earnings Presentation 9M 2024 21 October, 2024
Slide 2: Performance Highlights and Strategy
Performance Highlights and Strategy Care Medical Earnings Presentation – 21/10/24 2
Slide 3: Improved Operational Efficiency and Financial Performance in 9M 2024
Improved Operational Efficiency and Financial Performance in 9M 2024 Operating and financial performance highlights Revenue 9M 2024 1,082 504.0 Total patients 9M 2024 New branches 921 SAR mn thousand +6% year-on-year AlBalad Haram +18% year-on-year 489.0 Outpatients1 9M 2024 • Jeddah, KSA • Long-ter
Slide 4: Strategic Focus: Expansion, New Services, Efficiency, and Automation
Strategic Focus: Expansion, New Services, Efficiency, and Automation Overview of strategic initiatives New Services Home Healthcare Services Executive Health Check Rawdah Mental Health Center Started Home Healthcare Services to increase Launched executive health check to raise cash Introduced mental
Slide 5: Operating and Financial Performance
Operating and Financial Performance Care Medical Earnings Presentation – 21/10/24 5
Slide 6: Operational Trends
Operational Trends Growing patient numbers supported by new branches, offset by the completion of a significant contract Operational Highlights1,2 Inpatients Admissions Quarterly Trend SAR mn 9M2024 9M2023 YoY, % 9M2024 LfL YoY, % (Admissions) Inpatient admissions 15,008 15,967 -6% 14,867 -7% -1% Ou
Slide 7: Income Statement
Income Statement 9M 2024 profitability improvement driven by expanding operations, and cost control Income Statement Highlights Net Profit Development SAR mn 3Q2024 3Q2023 YoY, % 9M2024 9M2023 YoY, % (SAR mn) Revenues 326 275 +18% 921 782 +18% Cost of revenues (214) (184) +17% (591) (519) +14% +19%
Slide 8: Revenue Trends
Revenue Trends Revenue in 9M 2024 supported by increasing number of referrals from key clients Revenue Development1 Revenue by Business Unit (9M 2024) (SAR mn) (SAR mn) 4 +18% 4 3 19 921 3 Malaz branch, 41.8% 41 2 SAR 921mn Rawabi branch, 49.2% (2) (3) 2 1 85 1 AlBalad branch, 8.5% 0 Haram branch, 0
Slide 9: Costs Overview
Costs Overview Gross margin benefits from cost of revenues increasing at a slower pace than revenue Total Expenses Breakdown (9M 2024) Cost of Revenues Breakdown (9M 2024) +20% (SAR mn) (SAR mn) 4 65.4% Operating expenses, 17.0% Salaries & benefits 4 9M 2024 YoY 3 24.7% 3 Medicines & consumables 1.6
Slide 10: Balance Sheet Highlights
Balance Sheet Highlights Strong balance sheet supported by a cash reserve and efficient cash conversion cycle Balance Sheet Highlights Cash Conversion Cycle1 Trend SAR mn 3Q2024 4Q2023 YtD, % (Days) Total Non-Current Assets 1,118 936 +19% +16% Total Current Assets 1,112 1,278 -13% Total Assets 2,230
Slide 11: Receivables Management
Receivables Management Growing receivables driven by higher number of referrals from key clients Trade Receivables1 Development Trade Receivables1 Structure (end of 3Q 2024) (SAR mn) (SAR mn) 48.1% GOSI +49% 23.1% MoH & Govt 16 984 20.5% 308 79 2 Insurance 4.0% Cash 4.4% (80) Other 659 Trade Receiva
Slide 12: Cash Flow Highlights
Cash Flow Highlights Stronger results support cash flow, counterbalanced by working capital increase Cash Flow Highlights Cash Flow From Operations Development SAR mn 3Q2024 3Q2023 YoY, % 9M2024 9M2023 YoY, % (SAR mn) Net Profit before zakat 69 82 -15% 209 202 +3% Non-cash adjustments 30 (2) NA 85 3
Slide 13: Q&A Session
Q&A Session Care Medical Earnings Presentation – 21/10/24 13
Slide 14: Appendix
Appendix Care Medical Earnings Presentation – 21/10/24 14
Slide 15: Operating Performance Overview (1/2)
Operating Performance Overview1 (1/2) Total Patients Trend Surgeries Trend (Thousand patients) (Thousand surgeries) +13% CAGR +16% CAGR 639 651 19 19 532 16 396 362 254 253 13 193 10 140 136 339 385 398 256 227 FY19 -9% FY20 +47% FY21 +20% FY22 +2% FY23 Rawabi branch Malaz branch FY19 +26% FY20 +20%
Slide 16: Operating Performance Overview (2/2)
Operating Performance Overview1 (2/2) Occupied Beds Trend Bed Occupancy Trend (Occupied beds) (%) -3% CAGR 80.3% 79.2% 78.8% 77.6% 516 526 508 519 464 70.8% 298 286 283 292 255 218 240 225 227 209 FY19 +2% FY20 -3% FY21 +2% FY22 -11% FY23 FY19 FY20 FY21 FY22 FY23 Rawabi branch Malaz branch Inpatient
Slide 17: Financial Performance Overview
Financial Performance Overview Total Revenue Trend EBITDA Trend (SAR mn) (SAR mn) +11% CAGR +15% CAGR 1,082 302 845 918 809 243 708 214 174 179 FY19 +14% FY20 +5% FY21 +9% FY22 +18% FY23 FY19 +3% FY20 +19% FY21 +13% FY22 +24% FY23 Net Profit Trend Margins Trend (SAR mn) (%) +32% CAGR 34.2% 24.5% 27.
Slide 18: Contacts
Contacts Institutional investor contact Alia Balbaa Investor Relations Director abalbaa@care.med.sa +966-11-418-4488 ext. 322 Investor Relations website https://ir.care.med.sa/ Care Medical Earnings Presentation – 21/10/24 18
Slide 19: Disclaimer
Disclaimer All information included in this document is for general use only and has not been independently verified, nor does it constitute or form part of any invitation or inducement to engage in any investment activity, nor does it constitute an offer or invitation or recommendation to buy or su
National Medical Care Co. (Care Medical) — 9M 2024 Earnings Presentation on 6ix